Acute Myeloid Leukemia Clinical Trials in Hangzhou, Zhejiang

17 recruitingHangzhou, Zhejiang, China

Showing 117 of 17 trials

Recruiting
Phase 1Phase 2

A Study of BGB-11417 in Participants With Myeloid Malignancies

Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasm
BeiGene260 enrolled46 locationsNCT04771130
Recruiting
Phase 2

Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid LeukemiaFLT3 Internal Tandem Duplication Positive+1 more
First Affiliated Hospital of Zhejiang University25 enrolled1 locationNCT07259707
Recruiting
Phase 2

Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

Newly Diagnosed Acute Myeloid Leukemia (AML)Intensive Chemotherapy UnfitAge ≥60
First Affiliated Hospital of Zhejiang University25 enrolled5 locationsNCT07172204
Recruiting
Phase 1

Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
Second Affiliated Hospital, School of Medicine, Zhejiang University48 enrolled1 locationNCT07263906
Recruiting
Phase 3

A Pivotal Study of APG-2575 (Lisaftoclax) Combined With Azacitidine in the Treatment of Acute Myeloid Leukemia

Acute Myeloid Leukemia
Ascentage Pharma Group Inc.486 enrolled6 locationsNCT06389292
Recruiting
Phase 1

A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia

CAR-T Cell TherapyAcute Myeloid Leukemia (AML)
First Affiliated Hospital of Zhejiang University20 enrolled1 locationNCT07198867
Recruiting
Not Applicable

Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study)

Acute Myeloid LeukemiaMyelodysplastic SyndromesHigh-Risk Acute Myeloid Leukemia+1 more
First Affiliated Hospital of Zhejiang University138 enrolled1 locationNCT07183878
Recruiting
Early Phase 1

Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia

Acute Myeloid Leukemia
Zhejiang University50 enrolled1 locationNCT07144020
Recruiting
Phase 1

A Study of GLB-001 in Patients With Myeloid Malignancies

Acute Myeloid LeukemiaMyelodysplastic SyndromesMyelofibrosis+3 more
Hangzhou GluBio Pharmaceutical Co., Ltd.108 enrolled14 locationsNCT06378437
Recruiting
Phase 3

A Study to Evaluate HMPL-306 in Patients With IDH1or IDH2-mutated Acute Myeloid Leukemia

Acute Myeloid Leukemia
Hutchmed316 enrolled53 locationsNCT06387069
Recruiting
Phase 1

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

Hematologic MalignancyAML (Acute Myelogenous Leukemia)Refractory Acute Myeloid Leukemia+3 more
Hangzhou Weben Pharma Co., Ltd18 enrolled1 locationNCT07014449
Recruiting
Early Phase 1

A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia
Zhejiang University27 enrolled1 locationNCT06762132
Recruiting
Phase 2

Mitoxantrone Hydrochloride Liposome in Combination With Cytarabine and Venetoclax Regimen in Newly Diagnosed Elderly AML

Acute Myeloid Leukemia
First Affiliated Hospital of Zhejiang University42 enrolled1 locationNCT06621199
Recruiting
Phase 4

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

Acute Myeloid Leukemia
He Huang118 enrolled1 locationNCT06571825
Recruiting
Not Applicable

Individualized Treatment of Pediatric R/R AML Based on Transcriptomic Profile and in Vitro Drug Sensitivity Test

Acute Myeloid Leukemia in Children
The Children's Hospital of Zhejiang University School of Medicine60 enrolled1 locationNCT06233526
Recruiting
Phase 2

Prolonged Ultra Low-dose Decitabine Plus Venetoclax for Primary Diagnosed Elderly AMLK/MDS

Acute Myeloid LeukemiaMyelodysplastic Syndromes
First Affiliated Hospital of Zhejiang University120 enrolled1 locationNCT06046313
Recruiting
Early Phase 1

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

Acute Myeloid LeukemiaMultiple MyelomaNon-Hodgkin's Lymphoma
Zhejiang University108 enrolled1 locationNCT04662294